- 2025-07-27 17:56GPR10 agonist 1
- 2025-07-27 17:55GnRH-R antagonist 1 2826273-90-7
- 2025-07-27 17:55GnRH Associated Peptide (GAP) (1-13), human 100111-07-7
- 2025-07-27 17:55GnRH Associated Peptide (25-53), human (GAP (25-53), human) 106061-19-2
- 2025-07-27 17:55GnRH Associated Peptide (1-24), human (GAP (1-24), human) 148943-65-1
- 2025-07-27 17:55GnRH antagonist 2 1709823-61-9
- 2025-07-27 17:55Fsh receptor-binding inhibitor fragment(bi-10) 163973-98-6
- 2025-07-27 17:55DCOIT (Kathon 930) 64359-81-5
- 2025-07-27 17:54BAY-899 2471967-92-5
- 2025-07-27 17:54V-0219 hydrochloride 2922283-73-4
- 2025-07-27 17:54BAY-298 2471978-97-7
- 2025-07-27 17:54Azaline B 134457-28-6
- 2025-07-27 17:54Hyodeoxycholic acid 83-49-8
- 2025-07-27 17:54Acyline TFA
- 2025-07-27 17:54SBI-115 882366-16-7
- 2025-07-27 17:54BAR-501 1632118-69-4
- 2025-07-27 17:54Abarelix Acetate (Abarelix Acetate; PPI 149 Acetate; R 3827 Acetate) 547741-72-0
- 2025-07-27 17:54Tirzepatide hydrochloride (LY3298176 hydrochloride)
- 2025-07-27 17:54[D-Lys6]-LH-RH 52671-12-2
- 2025-07-27 17:53[D-Leu6, Val7]-LH-RH (1-9) Ethyl Amide
